GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (LTS:0A4N) » Definitions » Cyclically Adjusted Book per Share

Genetic Technologies (LTS:0A4N) Cyclically Adjusted Book per Share : $20.06 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Genetic Technologies Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Genetic Technologies's adjusted book value per share for the three months ended in Jun. 2024 was $0.276. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $20.06 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Genetic Technologies's average Cyclically Adjusted Book Growth Rate was -34.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -24.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Genetic Technologies was -8.10% per year. The lowest was -24.70% per year. And the median was -14.10% per year.

As of today (2024-12-14), Genetic Technologies's current stock price is $0.775. Genetic Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was $20.06. Genetic Technologies's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genetic Technologies was 2.18. The lowest was 0.03. And the median was 0.62.


Genetic Technologies Cyclically Adjusted Book per Share Historical Data

The historical data trend for Genetic Technologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Cyclically Adjusted Book per Share Chart

Genetic Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 43.81 27.29 20.06

Genetic Technologies Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 24.64 - 20.06 -

Competitive Comparison of Genetic Technologies's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Genetic Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetic Technologies's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's Cyclically Adjusted PB Ratio falls into.



Genetic Technologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genetic Technologies's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book= Book Value per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.276/128.9064*128.9064
=0.276

Current CPI (Jun. 2024) = 128.9064.

Genetic Technologies Quarterly Data

Book Value per Share CPI Adj_Book
200912 60.609 87.578 89.210
201006 32.699 88.971 47.376
201012 67.758 89.993 97.057
201106 48.574 92.129 67.964
201112 87.501 92.686 121.695
201203 0.000 92.779 0.000
201206 85.752 93.244 118.549
201212 66.557 94.730 90.570
201303 0.000 95.101 0.000
201306 31.353 95.473 42.333
201312 31.462 97.330 41.669
201406 7.808 98.352 10.234
201412 0.825 99.002 1.074
201506 23.880 99.838 30.833
201512 18.898 100.673 24.198
201606 14.358 100.859 18.351
201612 12.426 102.159 15.679
201706 9.200 102.809 11.535
201712 6.446 104.110 7.981
201806 4.061 104.945 4.988
201812 2.292 105.967 2.788
201906 1.172 106.617 1.417
201912 1.455 107.917 1.738
202006 3.856 106.246 4.678
202009 0.000 107.917 0.000
202012 4.780 108.846 5.661
202103 0.000 109.496 0.000
202106 5.477 110.332 6.399
202109 0.000 111.168 0.000
202112 4.520 112.654 5.172
202203 0.000 115.069 0.000
202206 3.751 117.112 4.129
202209 0.000 119.248 0.000
202212 2.418 121.477 2.566
202303 0.000 123.148 0.000
202306 1.947 124.170 2.021
202309 0.000 125.656 0.000
202312 0.837 126.399 0.854
202403 0.000 127.606 0.000
202406 0.276 128.906 0.276

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Genetic Technologies  (LTS:0A4N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Genetic Technologies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.775/20.06
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genetic Technologies was 2.18. The lowest was 0.03. And the median was 0.62.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Genetic Technologies Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetic Technologies Business Description

Traded in Other Exchanges
Address
60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Genetic Technologies Headlines

No Headlines